Skip to main content

Table 4 Occurrence of hypercalciuria according to calcium and/or vitamin D supplementation (top) and baseline menopausal status (bottom)

From: Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancer

Vitamin D and/or calcium supplementation (N = 66)

 

Yes (n = 9)

No (n = 58)

p-value

Hypercalciuria

No

5

62.5 [20.8–91.3]

38

65.5 [52.1–76.9]

0.7

Yes

3

37.5 [8.7–79.2]

20

34.5 [23.1–47.9]

Baseline Menopausal status (N = 81)

 

Yes (n = 46)

No (n = 35)

 

Hypercalciuria

No

30

65.2 [50–77.9]

23

65.7 [47.9–80]

0.4

Yes

16

34.8 [22.1–50]

12

34.3 [20–52.1]